Panzyga for the Belfast Trust comes from Sciensus Pharma Services
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct
- 21 May 2026 to 31 March 2028
Belfast Health and Social Care Trust is buying Panzyga, an immunoglobulin given by infusion, from Sciensus Pharma Services Limited. The medicine is for patient treatment at the trust, under a 22-month supply contract.
The trust awarded the contract directly in May 2026. It is worth £150,000 and runs to March 2028.
Contract ends March 2028
- What
- Blood products and plasma-derived medicines
- Supplier
- Sciensus Pharma Services Limited
- Value
- £150,000
- How it was bought
- Direct
- Dates and next
- May 2026 to Mar 2028